These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. Spronk PE, ter Borg EJ, Huitema MG, Limburg PC, Kallenberg CG. Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951 [Abstract] [Full Text] [Related]
3. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8. Dooley MA, Cush JJ, Lipsky PE, Dawson DV, Pisetsky DS. J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770 [Abstract] [Full Text] [Related]
6. Immune function in patients with acute pancreatitis. Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y. J Gastroenterol Hepatol; 2003 Apr; 18(4):363-70. PubMed ID: 12653883 [Abstract] [Full Text] [Related]
7. Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. De Rie MA, Zonneveld IM, Witkamp L, Van Lier RA, Out TA, Bos JD. Acta Derm Venereol; 1996 Sep; 76(5):357-60. PubMed ID: 8891007 [Abstract] [Full Text] [Related]
8. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate. Smid WM, Martens A, van der Meer J, Hegge-Paping CS, Halie MR. Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495 [Abstract] [Full Text] [Related]
12. Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas' disease. Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G. Clin Diagn Lab Immunol; 2002 Nov; 9(6):1324-7. PubMed ID: 12414768 [Abstract] [Full Text] [Related]
14. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Beguin Y, Lampertz S, De Groote D, Igot D, Malaise M, Fillet G. Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102 [Abstract] [Full Text] [Related]
15. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome. Sawada S, Sugai S, Iijima S, Takei M, Paredes E, Hayama T, Nishinarita S, Hosokawa Y, Horie T, Obara T. Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196 [Abstract] [Full Text] [Related]
20. Clinical significance of serial measurement of the serum levels of soluble interleukin-2 receptor and soluble CD8 in malignant lymphoma. Motokura T, Kobayashi Y, Fujita A, Nakamura Y, Taniguchi T, Uchimaru K, Asano S. Leuk Lymphoma; 1995 Jan; 16(3-4):355-62. PubMed ID: 7719243 [Abstract] [Full Text] [Related] Page: [Next] [New Search]